The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Brain Research. Molecular Brain Research

• Publication date

  1996-09-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0169-328X(96)00062-9PMID 8883930
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BDNF attenuates the effects of intrastriatal injection of 6‐hydroxydopamine

  1995cited by this paper
• Functional interactions of neurotrophins and neurotrophin receptors.

  1995cited by this paper
• 1-Methyl-4-phenyl-pyridinium (MPP+) uptake does not explain the differential toxicity of MPP+ in the nigrostriatal and mesolimbic dopaminergic pathways.

  1995cited by this paper
• Brain-derived neurotrophic factor increases the electrical activity of pars compacta dopamine neurons in vivo.

  1994cited by this paper
• Neurotrophic‐4/5 is a survival factor for embryonic midbrain dopaminergic neurons in enriched cultures

  1994cited by this paper
• 6-Hydroxydopamine lesions reduce BDNF mRNA levels in adult rat brain substantia nigra.

  1994cited by this paper
• Functions of brain-derived neurotrophic factor, insulin-like growth factor-I and basic fibroblast growth factor in the development and maintenance of dopaminergic neurons.

  1994cited by this paper
• Expression of neurotrophins by midbrain dopaminergic neurons.

  1993cited by this paper
• The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons.

  1992cited by this paper
• The gene encoding hypoxanthine-guanine phosphoribosyltransferase as target for mutational analysis: PCR cloning and sequencing of the cDNA from the rat.

  1992cited by this paper
• Cellular localization of tyrosine hydroxylase mRNA and cholecystokinin mRNA-containing cells in the ventral mesencephalon of the common marmoset: effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1992cited by this paper
• Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo.

  1992cited by this paper
• Brain-derived neurotrophic factor and neurotrophin-3 mRNAs are expressed in ventral midbrain regions containing dopaminergic neurons.

  1992cited by this paper
• Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes

  1992cited by this paper
• Brain-derived neurotrophic factor administration protects basal forebrain cholinergic but not nigral dopaminergic neurons from degenerative changes after axotomy in the adult rat brain

  1992cited by this paper
• Brain‐Derived Neurotrophic Factor Protects Dopamine Neurons Against 6‐Hydroxydopamine and N‐Methyl‐4‐Phenylpyridinium Ion Toxicity: Involvement of the Glutathione System

  1992cited by this paper
• Primary structure of mouse tyrosine hydroxylase deduced from its cDNA.

  1991cited by this paper
• Tyrosine Hydroxylase mRNA Expression by Dopaminergic Neurons in Culture: Effect of 1 ‐Methyl‐4‐Phenylpyridinium Treatment

  1991cited by this paper
• BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra

  1991cited by this paper
• A computer program for selection of oligonucleotide primers for polymerase chain reactions.

  1990cited by this paper
• Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture.

  1990cited by this paper
• Regional distribution of brain‐derived neurotrophic factor mRNA in the adult mouse brain.

  1990cited by this paper
• Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis.

  1990cited by this paper
• Molecular cloning and expression of brain-derived neurotrophic factor

  1989cited by this paper
• Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease

  1988cited by this paper
• Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF.

  1987cited by this paper
• Nucleotide sequence and organization of the mouse adenine phosphoribosyltransferase gene: presence of a coding region common to animal and bacterial phosphoribosyltransferases that has a variable intron/exon arrangement.

  1985cited by this paper
• Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.

  1985cited by this paper
• Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

  1984cited by this paper
• N-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine (MPTP) causes destruction of the nigrostriatal but not the mesolimbic dopamine system in the monkey.

  1984cited by this paper
• Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

  1984cited by this paper
• Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

  1983cited by this paper
• High-performance liquid chromatographic determination of indoleamines, dopamine, and norepinephrine in rat brain with fluorometric detection.

  1983cited by this paper
• A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

  1983cited by this paper
• Distribution of Catecholamines in the Ventral Mesencephalon of Human Brain, with Special Reference to Parkinson's Disease

  1981cited by this paper
• Central catecholamine neuron systems: anatomy and physiology of the dopamine systems.

  1978cited by this paper
• Tyrosine hydroxylase activity: regional and subcellular distribution in the brain.

  1974cited by this paper
• Genetic regulation of the catecholamine biosynthetic enzymes. II. Inheritance of tyrosine hydroxylase, dopamine-beta-hydroxylase, and phenylethanolamine N-methyltransferase.

  1974cited by this paper
• Tyrosine hydroxylase activity: Regional and subcellular distribution in brain

  1974cited by this paper
• Statistical Principles in Experimental Design

  1963cited by this paper

• Ultrastructural Dynamics of Dopaminergic Presynaptic Release Sites revealed by Cryo-correlative Light and Electron Microscopy

  2024cites this paper
• Nigrostriatal inflammation is associated with nonmotor symptoms in an experimental model of prodromal Parkinson's disease.

  2024cites this paper
• Iron accumulation in the ventral tegmental area in Parkinson's disease

  2023cites this paper
• New Frontiers in Neurodegeneration and Regeneration Associated with Brain-Derived Neurotrophic Factor and the rs6265 Single Nucleotide Polymorphism

  2022cites this paper
• The Function of BDNF and Treatment in Neurological Disorder

  2022cites this paper
• The Role of Astrocytes in the Neurorepair Process

  2021cites this paper
• ERRγ ligand HPB2 upregulates BDNF-TrkB and enhances dopaminergic neuronal phenotype.

  2021cites this paper
• The effects of BDNF Knockdown on Neuroinflammation in the Male and Female rat brain

  2020cites this paper
• BDNF levels and nigrostriatal degeneration in "drug naïve" Parkinson's disease patients. An "in vivo" study using I-123-FP-CIT SPECT.

  2020cites this paper
• BDNF as a Promising Therapeutic Agent in Parkinson’s Disease

  2020cites this paper
• Serum level of brain‐derived neurotrophic factor in Parkinson's disease: a meta‐analysis

  2019cites this paper
• The neuropsychological deficits and dissociations in Huntington Disease-Like 2: A series of case-control studies.

  2019cites this paper
• Lactoferrin ameliorates dopaminergic neurodegeneration and motor deficits in MPTP-treated mice

  2018cites this paper
• Comparative analysis of Parkinson's disease–associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons

  2018cites this paper
• Comparative analysis of Parkinson's disease–associated genes reveals altered survival and bioenergetics of parkin-deficient dopamine neurons in mice

  2018cites this paper
• Research Progress in the Effect of Traditional Chinese Medicine for Invigoration on Neurotransmitter Related Diseases

  2018cites this paper
• Integral Characterization of Defective BDNF/TrkB Signalling in Neurological and Psychiatric Disorders Leads the Way to New Therapies

  2017cites this paper
• Functional analysis of lifeguard proteins Faim2 and GRINA in the MPTP mouse model of Parkinson disease

  2017cites this paper
• An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition

  2017cites this paper
• Serum brain-derived neurotrophic factor levels in treatment-naïve boys with attention-deficit/hyperactivity disorder treated with methylphenidate: an 8-week, observational pretest–posttest study

  2017cites this paper
• Targeting phosphodiesterase type 4 for improving cognitive fronto-striatal functioning: a translational approach

  2017cites this paper
• Neurotoxin 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Induced Animal Models of Parkinson’s Disease

  2017cites this paper
• Ageing of the somatic motor nervous system: a nuclear and mitochondrial genome perspective

  2016cites this paper
• Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications

  2016cites this paper
• Mice lacking Faim2 show increased cell death in the MPTP mouse model of Parkinson disease

  2016cites this paper
• Vinpocetine attenuates MPTP-induced motor deficit and biochemical abnormalities in Wistar rats.

  2015cites this paper
• Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons.

  2015cites this paper
• Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons

  2015cites this paper
• Executive function deficits and glutamatergic protein alterations in a progressive 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine mouse model of Parkinson's disease

  2015cites this paper
• ge-related gene expression changes in substantia nigra dopamine eurons of the rat

  2015cites this paper
• Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine.

  2014cites this paper
• BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis.

  2014cites this paper
• Phosphodiesterases: Regulators of cyclic nucleotide signals and novel molecular target for movement disorders.

  2013cites this paper
• Behavioral characterization of the 6-hydroxidopamine model of Parkinson’s disease and pharmacological rescuing of non-motor deficits

  2013cites this paper
• Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Animal Models for Parkinson's Disease

  2013cites this paper
• RESTORATION OF MOTOR AND NON-MOTOR FUNCTIONS BY NEUROTROPHIC FACTORS IN NONHUMAN PRIMATES WITH DOPAMINE DEPLETION

  2013cites this paper
• Molecular and Cellular Characterization of Dopamine Neuron Stimulating Peptides

  2013cites this paper
• Epigenetic regulation of BDNF-TrkB signaling in the pathophysiology and treatment of mood disorders

  2013cites this paper
• Uncoupling of ATP-depletion and cell death in human dopaminergic neurons.

  2012cites this paper
• A putative model of overeating and obesity based on brain-derived neurotrophic factor: direct and indirect effects.

  2012cites this paper
• Protective effect of extract of Acanthopanax senticosus Harms on dopaminergic neurons in Parkinson's disease mice.

  2012cites this paper
• Degeneration mechanisms in human dopaminergic neurons

  2012cites this paper
• Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression.

  2012cites this paper
• Identifying Associative Memory Deficits And Neurobiological Correlates Of Encoding And Performance In A National Sample Of Veterans With Gulf War Illness Using Magnetic Resonance Imaging

  2012cites this paper
• Développement d'un modèle animal chez le rat reproduisant un déficit motivationnel pouvant s'apparenter à un syndrome d'apathie de la maladie de Parkinson

  2012cites this paper
• The development of encapsulated cell technologies as therapies for neurological and sensory diseases.

  2012cites this paper
• TrkB inhibition as a therapeutic target for CNS-related disorders.

  2012cites this paper
• Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

  2011influential citation
• Influence of TPH2 variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia.

  2011cites this paper
• Increased iron levels correlate with the selective nigral dopaminergic neuron degeneration in Parkinson’s disease

  2011cites this paper
• Granulocyte macrophage-colony stimulating factor protects against substantia nigra dopaminergic cell loss in an environmental toxin model of Parkinson's disease

  2011cites this paper
• Influence of BDNF Variants on Diagnosis and Response to Treatment in Patients with Major Depression, Bipolar Disorder and Schizophrenia

  2011cites this paper
• Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function.

  2010cites this paper
• Estrogen Reduces BDNF Level, but Maintains Dopaminergic Cell Density in the Striatum of MPTP Mouse Model

  2010cites this paper
• Neurotrophic factor therapy for Parkinson's disease.

  2010cites this paper
• Novel D3 dopamine receptor‐preferring agonist D‐264: Evidence of neuroprotective property in Parkinson's disease animal models induced by 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine and lactacystin

  2010cites this paper
• Increased Opioid Dependence in a Mouse Model of Panic Disorder

  2009cites this paper
• Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease.

  2009cites this paper
• Phenotype, compartmental organization and differential vulnerability of nigral dopaminergic neurons.

  2009cites this paper
• Brain-derived neurotrophic factor in neurodegenerative diseases

  2009cites this paper
• Synthetic and Natural Environmental Compounds as Potential Facilitators of Mptp-Induced Parkinsonism

  2009cites this paper
• Birth, life and death of dopaminergic neurons in the substantia nigra.

  2009cites this paper
• PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson's disease

  2008cites this paper
• BDNF and the diseased nervous system: a delicate balance between adaptive and pathological processes of gene regulation

  2008cites this paper
• MPTP-treated mice: long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations

  2008cites this paper
• Aging of the rat mesostriatal system: differences between the nigrostriatal and the mesolimbic compartments.

  2007cites this paper
• Genotype and childhood sexual trauma moderate neurocognitive performance: a possible role for brain-derived neurotrophic factor and apolipoprotein E variants.

  2007cites this paper
• Brain-derived neurotrophic factor in schizophrenia and its relation with dopamine.

  2007cites this paper
• Reduced brain‐derived neurotrophic factor is associated with a loss of serotonergic innervation in the hippocampus of aging mice

  2007cites this paper
• The molecular genetics of cognition: dopamine, COMT and BDNF

  2006cites this paper
• Essential Role of BDNF in the Mesolimbic Dopamine Pathway in Social Defeat Stress

  2006cites this paper
• Shedding light into the role of BDNF in the pharmacotherapy of Parkinson's disease

  2006cites this paper
• Decrease in α3*/α6* Nicotinic Receptors but Not Nicotine-Evoked Dopamine Release in Monkey Brain after Nigrostriatal Damage

  2005cites this paper
• Brain-Derived Neurotrophic Factor Is Required for the Establishment of the Proper Number of Dopaminergic Neurons in the Substantia Nigra Pars Compacta

  2005cites this paper
• Decrease in (cid:1) 3*/ (cid:1) 6* Nicotinic Receptors but Not Nicotine-Evoked Dopamine Release in Monkey Brain after Nigrostriatal Damage

  2005cites this paper
• BDNF in schizophrenia, depression and corresponding animal models

  2005cites this paper
• Decrease in alpha3*/alpha6* nicotinic receptors but not nicotine-evoked dopamine release in monkey brain after nigrostriatal damage.

  2005cites this paper
• LE NEUROTROFINE COME POSSIBILI FATTORI DI MEDIAZIONE DELL’AZIONE DEI FARMACI ANTIPSICOTICI SUL SISTEMA DOPAMINERGICO: IL RUOLO DEL NERVE GROWTH FACTOR E DEL BRAIN-DERIVED NEUROTROPHIC FACTOR

  2005cites this paper
• Maturation but not survival of dopaminergic nigrostriatal neurons is affected in developing and aging BDNF-deficient mice.

  2005cites this paper
• MPTP Treatment Impairs Tyrosine Hydroxylase Immunopositive Fibers Not Only in the Striatum, but Also in the Amygdala

  2005cites this paper
• Brain-derived neurotrophic factor as a drug target for CNS disorders

  2004cites this paper
• Behavioral Neuroscience

  2004cites this paper
• Neurogenesis in olfactory bulb identified by retroviral labeling in normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated adult mice.

  2004cites this paper
• Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression.

  2003cites this paper
• Expression of BDNF mRNA in substantia nigra is dependent on target integrity and independent of neuronal activation

  2003influential citation
• Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity by the novel selective dopamine D3-receptor partial agonist FAUC 329 predominantly in the nucleus accumbens of mice.

  2003cites this paper
• Effect of 6-hydroxydopamine on striatal GDNF and nigral GFRalpha1 and RET mRNAs in the adult rat.

  2003cites this paper
• Chromosomal Loci Influencing the Susceptibility to the Parkinsonian Neurotoxin 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine

  2003cites this paper
• Increased striatal neuropeptide Y immunoreactivity and its modulation by deprenyl, clonidine and L-dopa in MPTP-treated mice

  2003cites this paper
• Neutralization of neutrophin‐3 in the ventral tegmental area or nucleus accumbens differentially modulates cocaine‐induced behavioral plasticity in rats

  2002cites this paper
• Lack of Effect of Testosterone and Dihydrotestosterone Compared to 17β‐Oestradiol in 1‐Methyl‐4‐Phenyl‐1,2,3,6, Tetrahydropyridine‐Mice

  2002cites this paper
• Protective role of melatonin against MPTP-induced mouse brain cell DNA fragmentation and apoptosis in vivo.

  2001cites this paper
• Strain‐dependent susceptibility to MPTP and MPP+‐induced Parkinsonism is determined by glia

  2001cites this paper
• Suszeptibilitätsunterschiede im MPTP-Mausmodell für Morbus Parkinson: Untersuchung genetischer Einflußfaktoren anhand von Stammvergleichen

  2001cites this paper
• Strain-Dependen tSusceptibilit yto MPT Pan dMPP 1 -Induced Parkinsonis mI sDetermine db yGlia

  2001cites this paper
• Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease.

  2001cites this paper
• Evidence for a dissociation between MPTP toxicity and tyrosinase activity based on congenic mouse strain susceptibility.

  2001cites this paper
• Intuition: a social cognitive neuroscience approach.

  2000cites this paper
• MPTP Susceptibility in the Mouse: Behavioral, Neurochemical, and Histological Analysis of Gender and Strain Differences

  2000cites this paper
• Immunolocalization of the cocaine‐ and antidepressant‐sensitive l‐norepinephrine transporter

  2000cites this paper